Body dysmorphic disorder: diagnostic controversies and treatment challenges.
Body dysmorphic disorder (BDD) is a distressing, impairing, and relatively common yet underrecognized disorder. This clinically focused article discusses the following diagnostic controversies and challenges associated with BDD: the underdiagnosis and misdiagnosis of BDD, the relationship between BDD and obsessive-compulsive disorder, the relationship between BDD and depression, the delusionality controversy, and whether BDD can be diagnosed in children and adolescents. This article also discusses treatment controversies and challenges associated with serotonin reuptake inhibitors, antipsychotics, cognitive-behavioral therapy, approaches to treatment-resistant BDD, and getting reluctant patients to accept psychiatric treatment.
Phillips
K A
KA
Butler Hospital, Providence, RI 02906, USA.
D000328:Adult; D000367:Age Factors; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002648:Child; D015928:Cognitive Behavioral Therapy; D003702:Delusions / Q000175:diagnosis; D003863:Depression / Q000175:diagnosis*; D003937:Diagnosis, Differential; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013001:Somatoform Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy*
D014150:Antipsychotic Agents; D017367:Selective Serotonin Reuptake Inhibitors